ITGB1 and glioblastoma: Similarly, analysis of ITGB1 expression using the TIMER database showed overexpression in several cancers, including CHOL, esophageal carcinoma (ESCA), glioblastoma (GBM), KIRC, and LIHC (Figure 3E).